Emergence of carbapenemase KPC-14 in an <i>Escherichia coli</i> isolate: a case report. [PDF]
Fontán García-Rodrigo L +4 more
europepmc +1 more source
Longitudinal Multicenter Susceptibility Trends of Ceftazidime/Avibactam and Imipenem/Relebactam and Dose Optimization in Critically Ill Patients with Carbapenem-Resistant <i>Enterobacterales</i> Bloodstream Infections. [PDF]
Wang X +10 more
europepmc +1 more source
Characterization of KPC-287 conferring high-level ceftazidime-avibactam resistance in an ST11-KL64 <i>Klebsiella pneumoniae</i> isolate. [PDF]
Gong Y +6 more
europepmc +1 more source
<i>In vivo</i> emergence of ceftazidime/avibactam resistance in <i>Pseudomonas aeruginosa</i> driven by OXA-1381, a novel W157L Ω-loop variant of OXA-2. [PDF]
Pérez-Rodríguez G +8 more
europepmc +1 more source
Association of Carbapenemase Gene Profiles with Ceftazidime-avibactam Resistance in Carbapenem-Resistant <i>Klebsiella pneumoniae</i>. [PDF]
Güner ET, Bakır A, Çiçek C, Aral M.
europepmc +1 more source
Phenotypic and Genotypic Evaluation of Carbapenemases in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Isolates and Investigation of Ceftazidime-Avibactam and Colistin Susceptibility. [PDF]
Torun EG, Okumuş E, Kaya E.
europepmc +1 more source
Combating Carbapenem-Resistant <i>Enterobacterales</i>: Comparative <i>In Vitro</i> Efficacy of Aztreonam-Avibactam and Ceftazidime-Avibactam and Distribution of Carbapenemase Genes. [PDF]
Yaşar Duman M +4 more
europepmc +1 more source
Real-World Use of Ceftazidime-Avibactam for Carbapenem-Resistant Enterobacterales Infections in Children: A 7-Year Cohort from a Latin American Referral Center. [PDF]
Novoa Villada MG +6 more
europepmc +1 more source
Global epidemiology of carbapenem-resistant <i>Pseudomonas aeruginosa</i>. [PDF]
Gottesdiener LS, Satlin MJ.
europepmc +1 more source
Disseminated <i>Klebsiella pneumoniae</i> Infection Causing Multisystem Abscesses and Necrotising Fasciitis in an Immunocompetent Patient: A Case Report. [PDF]
Yi Q, Huang Y, Cao H, Zhang X.
europepmc +1 more source

